Milgamma N

Thiamine Hydrochloride, Pyridoxine Hydrochloride and Cyanocobalamin, the active ingredients in Milgamma N, are a vitamin B complex supplement presented as an injectable solution for intramuscular use. It addresses deficiencies of vitamins B1, B6 and B12 and related neurological or hematologic conditions.

GNH USA supplies Milgamma N as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Milgamma N is a vitamin B complex used to correct deficiencies and associated disorders in the nervous and hematologic systems. - Vitamin B1 deficiency (thiamine deficiency): restores thiamine levels and supports carbohydrate metabolism. - Vitamin B6 deficiency (pyridoxine deficiency): replenishes pyridoxine and aids neurotransmitter synthesis. - Vitamin B12 deficiency (cobalamin deficiency): corrects cobalamin shortage and promotes normal hematopoiesis. - Peripheral neuropathy associated with B‑vitamin deficiency: alleviates nerve dysfunction symptoms. - Megaloblastic anemia due to B12 deficiency: improves red blood cell formation.

Adverse reactions may occur following intramuscular administration of Milgamma N.

Common Side Effects: - Injection site pain or erythema. - Mild fever or chills. - Headache. - Nausea. - Dizziness.

Serious or Rare Side Effects: - Anaphylactic reaction. - Severe hypersensitivity (e.g., angio‑edema). - Stevens‑Johnson syndrome. - Thrombophlebitis at injection site. - Severe hypotension. - Serum sickness‑like reaction.

Milgamma N should be used with attention to patient‑specific factors and proper handling. - Allergy assessment: verify no known hypersensitivity to any B‑vitamin component. - Pregnancy and lactation: use only if benefits outweigh risks after medical evaluation. - Renal or hepatic impairment: monitor closely and adjust therapy if required. - Concurrent vitamin therapy: avoid excessive combined B‑vitamin dosing. - Store at ambient temperature (below 25°C): keep in original packaging, protect from moisture and light.

Milgamma N may interact with other medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Methotrexate: may increase toxicity due to folate antagonism. - Anticonvulsants (e.g., phenytoin, phenobarbital): may reduce B‑vitamin levels. - Cimetidine: may impair absorption of cyanocobalamin.

Moderate Interactions (Monitor Closely): - High‑dose vitamin C: may increase urinary excretion of pyridoxine. - Oral contraceptives: may alter B‑vitamin metabolism. - Chronic alcohol use: may increase thiamine requirement. - Proton‑pump inhibitors: may affect B12 absorption.